Xcout IntelGemmabio
GEMMABio is a privately held therapeutics company founded in 2024 in Philadelphia, Pennsylvania, dedicated to developing novel gene therapies for rare diseases.
Subscribe to see Gemmabio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Gemmabio at a glance
Gemmabio is a healthcare company headquartered in United States. Its most recent funding round, Seed, raised $34M in December 2024. Xcout tracks 6 named people at Gemmabio, including Annalisa Jenkins (Chair).
Gemmabio leadership
- Annalisa JenkinsChair
- Dr. Jim Wilsonfounder
- James M. WilsonFounder
- Campbell MurrayBoard Member
- Florent GrosBoard Member
- John MaraganoreBoard Member
Gemmabio funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $34M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Gemmabio competitors
A few of Gemmabio's closest competitors — see the full list of competitors and alternatives →
GEn1E Lifesciences Inc. is a clinical-stage, Phase 2 biotechnology research company based in Palo Alto, California, focused on accelerating novel precision therapies.
Spot Biosystems is a gene therapy company pioneering a novel non-viral extracellular delivery approach. Headquartered in Palo Alto, California, the company launched with significant financing to advance its therapeutic pipeline.
GENEOS Therapeutics, Inc. is a biotechnology company focused on developing exquisitely personalized, EPIC-based cancer immunotherapies. The company is headquartered in Philadelphia, Pennsylvania, United States.
Belief BioMed Inc. is a globally innovative biotechnology company that integrates the development, manufacturing, and clinical application of gene therapy products. The company operates research centers, manufacturing facilities, and offices across multiple cities in China as well as the United States. Its primary operations are rooted in Shanghai, China.
GenEdit is a South San Francisco, California-based startup developing alternative methods of delivering gene-based and CRISPR-based medicines.
Code Biotherapeutics, Inc. is a biotechnology company headquartered in the Greater Philadelphia area. The firm focuses on next-generation gene therapies and advanced medicine.
Get Gemmabio's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Gemmabio in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access